# Voyager Therapeutics, Inc.: filings

VYGR · Nasdaq · CIK 1640266 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vygr.md) · [Financials](/companies/vygr/financials.md) · [Filings](/companies/vygr/filings.md) · [Insiders](/companies/vygr/insiders.md)

## Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 269, 8-K 113, 144 42, SC 13G/A 39, 3 36, 10-Q 33, SC 13G 17, S-8 13, SCHEDULE 13G/A 12, 10-K 11, DEF 14A 11, CORRESP 10, DEFA14A 7, UPLOAD 6, EFFECT 5, 424B5 4, ARS 4, CT ORDER 4, DRSLTR 4, S-1/A 4, S-3 4, 424B3 3, D 3, DRS/A 3, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, POS EX 1, PRE 14A 1, S-1 1, S-3/A 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 12:07 ET | [8-K](/filings/0001193125-26-427224.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-427224 |
| 2026-08-06 | 20:03 ET | [8-K](/filings/0001640266-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001640266-26-000007 |
| 2026-08-06 | 20:01 ET | [10-Q](/filings/0001640266-26-000006.md) | Quarterly report, period 2026-06-30 | 0001640266-26-000006 |
| 2026-07-13 | 12:44 ET | [8-K](/filings/0001104659-26-082906.md) | 8.01 Other events | 0001104659-26-082906 |
| 2026-06-10 | 20:05 ET | [8-K](/filings/0001104659-26-072324.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072324 |
| 2026-06-01 | 12:00 ET | [8-K](/filings/0001104659-26-068591.md) | 8.01 Other events | 0001104659-26-068591 |
| 2026-05-07 | 20:07 ET | [8-K](/filings/0001104659-26-057115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057115 |
| 2026-05-07 | 20:04 ET | [10-Q](/filings/0001104659-26-057097.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057097 |
| 2026-04-28 | 20:00 ET | [DEF 14A](/filings/0001104659-26-050297.md) | Proxy statement, period 2026-06-09 | 0001104659-26-050297 |
| 2026-04-21 | 20:05 ET | [8-K](/filings/0001104659-26-045997.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-045997 |
| 2026-03-09 | 20:04 ET | [8-K](/filings/0001104659-26-025201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-025201 |
| 2026-03-09 | 20:02 ET | [10-K](/filings/0001104659-26-025197.md) | Annual report, period 2025-12-31 | 0001104659-26-025197 |
| 2026-02-12 | 13:00 ET | [8-K](/filings/0001104659-26-013897.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-26-013897 |
| 2026-01-08 | 13:16 ET | [8-K](/filings/0001104659-26-001955.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001955 |
| 2025-11-10 | 13:01 ET | [10-Q](/filings/0001104659-25-108846.md) | Quarterly report, period 2025-09-30 | 0001104659-25-108846 |
| 2025-11-10 | 13:00 ET | [8-K](/filings/0001104659-25-108841.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-108841 |
| 2025-09-02 | 11:00 ET | [8-K](/filings/0001104659-25-085977.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-085977 |
| 2025-08-06 | 20:02 ET | [10-Q](/filings/0001558370-25-010511.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010511 |
| 2025-08-06 | 20:00 ET | [8-K](/filings/0001558370-25-010507.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010507 |
| 2025-06-05 | 20:13 ET | [8-K](/filings/0001104659-25-056835.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-056835 |
| 2025-05-06 | 20:02 ET | [10-Q](/filings/0001558370-25-006484.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006484 |
| 2025-05-06 | 20:01 ET | [8-K](/filings/0001558370-25-006482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006482 |
| 2025-04-23 | 20:01 ET | [DEF 14A](/filings/0001558370-25-005254.md) | Proxy statement, period 2025-06-03 | 0001558370-25-005254 |
| 2025-03-11 | 20:01 ET | [10-K](/filings/0001558370-25-002703.md) | Annual report, period 2024-12-31 | 0001558370-25-002703 |
| 2025-03-11 | 20:00 ET | [8-K](/filings/0001558370-25-002702.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002702 |
| 2025-02-11 | 12:07 ET | [8-K](/filings/0001104659-25-011155.md) | 8.01 Other events | 0001104659-25-011155 |
| 2024-11-12 | 21:01 ET | [10-Q](/filings/0001558370-24-015304.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015304 |
| 2024-11-12 | 21:00 ET | [8-K](/filings/0001558370-24-015299.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015299 |
| 2024-09-05 | 12:06 ET | [8-K](/filings/0001104659-24-097152.md) | 1.01 Entry into a material agreement | 0001104659-24-097152 |
| 2024-08-06 | 20:01 ET | [10-Q](/filings/0001558370-24-011073.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011073 |
| 2024-08-06 | 20:00 ET | [8-K](/filings/0001558370-24-011071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011071 |
| 2024-06-13 | 11:06 ET | [8-K](/filings/0001104659-24-071048.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-071048 |
| 2024-06-06 | 20:04 ET | [8-K](/filings/0001104659-24-069063.md) | 5.07 Shareholder vote results | 0001104659-24-069063 |
| 2024-05-16 | 11:05 ET | [8-K](/filings/0001104659-24-062257.md) | 8.01 Other events | 0001104659-24-062257 |
| 2024-05-13 | 20:01 ET | [10-Q](/filings/0001558370-24-007953.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007953 |
| 2024-05-13 | 20:00 ET | [8-K](/filings/0001558370-24-007951.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007951 |
| 2024-04-25 | 21:20 ET | [DEF 14A](/filings/0001558370-24-005793.md) | Proxy statement, period 2024-06-05 | 0001558370-24-005793 |
| 2024-04-02 | 20:05 ET | [8-K](/filings/0001104659-24-042502.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-042502 |
| 2024-03-13 | 11:03 ET | [8-K](/filings/0001104659-24-033726.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-033726 |
| 2024-02-28 | 21:01 ET | [10-K](/filings/0001558370-24-001988.md) | Annual report, period 2023-12-31 | 0001558370-24-001988 |
| 2024-02-28 | 21:00 ET | [8-K](/filings/0001558370-24-001987.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-001987 |
| 2024-01-08 | 21:49 ET | [8-K](/filings/0001104659-24-002271.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-002271 |
| 2024-01-02 | 12:05 ET | [8-K](/filings/0001104659-24-000084.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-24-000084 |
| 2023-12-06 | 12:04 ET | [8-K](/filings/0001104659-23-123809.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-123809 |
| 2023-11-06 | 21:01 ET | [10-Q](/filings/0001558370-23-017754.md) | Quarterly report, period 2023-09-30 | 0001558370-23-017754 |
| 2023-11-06 | 21:00 ET | [8-K](/filings/0001558370-23-017753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017753 |
| 2023-08-16 | 20:18 ET | [8-K](/filings/0001104659-23-092566.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-092566 |
| 2023-08-03 | 11:15 ET | [10-Q](/filings/0001558370-23-013058.md) | Quarterly report, period 2023-06-30 | 0001558370-23-013058 |
| 2023-08-03 | 11:00 ET | [8-K](/filings/0001558370-23-013047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013047 |
| 2023-07-10 | 12:04 ET | [8-K](/filings/0001104659-23-079340.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-079340 |

Page 1 of 4. [Older](/companies/vygr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.